Bicalutamide/ R-Bicalutamide

Detailed introduction to Bicalutamide/ R-Bicalutamide:

Bicalutamide/ R-Bicalutamide

[Molecule]: C18H14F4N2O4S
[Molecular Weight]: 430.37
Assay: 99.0%
CAS NO.: 90357-06-5

Characters: A white or almost white crystal powder, odorless, tasteless, freely soluble in DMF; Soluble in butylene oxide; Sparingly soluble in acetic ether and methanol; Insoluble in water.
Quality Standard: In-house C18H14F4N2O4S  above 99%
Usage: Prostate drug, It is developed by AstraZenca Internatioal, and it is the first antiandrogen non-corticosteroids drug for long-acting oral medication and firstly go on the market in 1995 in UK. An antiandrogen non-corticosteroids can be used treating prostate cancer in advanced stage as assistant drug, may also for treating prostate cancer in the early stage to play an important role.